Levofloxacin in 5% Dextrose Injection

5 mg/mL

500 mg/100 mL

Flexible Container

Unit of Sale NDC: 00409-3330-24

Limited
To set product alerts you must or register

Cap color: N/A

Wholesalers
Cardinal 5930573
Cencora 10290054
McKesson 2966968
Morris & Dickson 386870
Ordering information
Unit of Sale size 1 Carton of 24 Bags
Case size 1x24
Cases per tier 1
Cases per pallet 96
Unit of Sale dimensions 10.860x10.070x10.070
Unit of Sale weight 8.000
Unit of Sale per shipper 1
Shipper outer dimensions 10.860x10.070x10.070
Shipper weight 8.000
Allergy information
Non-DEHP
Latex information
Preservative free
Gluten free
Availability specifics
Additional information View

If Latex Information is present above, then natural rubber latex has not been used in the manufacturing of this device or drug container closure system.

If Preservative Free is present above, then this product does not contain ingredients identified as a preservative, as defined by the USP.

Cap color: N/A

Unit of Sale NDC:00409-3330-24

Levofloxacin in 5% Dextrose Injection

Unit of Use NDC:00409-3330-01

Levofloxacin in 5% Dextrose Injection

Related news

Product Updates

Product NDC Change: Fluconazole in Sodium Chloride Injection, USP 400 mg/200 mL (2 mg/mL) Flexible Container

Product Updates

Product NDC Change: Fluconazole in Sodium Chloride Injection, USP 200 mg/100 mL (2 mg/mL) Flexible Container

Product Updates

Product NDC and Pack Size Change: Marcaine® 0.5% (bupivacaine hydrochloride injection, USP) 50 mg/10 mL (5 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC Change: Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC Change: Midazolam Injection, USP CIV 2 mg/2 mL (1 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Changes for Camptosar® (Irinotecan Hydrochloride Injection, USP) 40 mg/2 mL (20 mg/mL) Single Dose Vial and Camptosar® (Irinotecan Hydrochloride Injection, USP) 100 mg/5 mL (20 mg/mL) Single Dose Vial

Product Updates

Product NDC and Pack Size Change: Marcaine® 0.5% (bupivacaine hydrochloride injection, USP) 250 mg/50 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change DOXOrubicin Hydrochloride Injection, USP 50 mg/25 mL (2 mg/mL) Single Dose Vial

Product Updates

Product NDC and Pack Size Changes for Lidocaine HCl 1% 200 mg/20 mL (10 mg/mL) and Epinephrine 1:100,000 Injection, USP Multiple Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for Metoclopramide Injection, USP 10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for DOXOrubicin Hydrochloride Injection, USP, Multiple Presentations

Product Updates

Product NDC Change for Idamycin PFS® (idarubicin hydrochloride injection) 5 mg/5 mL (1 mg/mL) Single Dose Vial

Product Updates

NDC and Pack Size Change for Sterile Empty Vial 10 mL Glass Bottle

Product Updates

Product NDC and Vial Presentation Change for DOXOrubicin Hydrochloride Injection, USP 200 mg/100 mL (2 mg/mL) Multiple Dose Vial

Product Updates

Product NDC and Vial Presentation Change for Camptosar® (Irinotecan Hydrochloride Injection, USP) 300 mg/15 mL (20 mg/mL) Single Dose Vial

Product Updates

NDC and Formulation Change for Levofloxacin in 5% Dextrose Injection Flexible Container Presentations

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 10 mg/10 mL (1 mg/mL) Single Dose Vial

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 20 mg/20 mL

Product Updates

Pfizer Hospital NDC and Packaging Change: Precedex

Product Updates

Pfizer Hospital NDC and Labeling Change: Morphine

Product Updates

NDC and Packaging Change for Labetalol Hydrochloride Injection, USP 100 mg/20 mL (5 mg/mL) Multiple-dose Vial

Product Updates

NDC and Labeling Change: Rocuronium Bromide NDC Labeling Change

Product Updates

NDC and Labeling Change Linezolid Injection in 0.9% Sodium Chloride 600 mg/300 mL (2 mg/mL) Single-dose Container

Product Updates

NDC and Labeling Change: Ciprofloxacin in 5% Dextrose Injection, USP 200 mg/100 mL (2 mg/mL) Single-Dose Flexible Container

Product Updates

NDC and Labeling Change for Magnesium Sulfate in Water for Injection 40 g/1000 mL (40 mg/mL) Single-Dose Flexible Container

Product Updates

NDC Updates

Product Updates

Product NDC Change for Ciprofloxacin in 5% Dextrose Injection, USP 400 mg/200 mL (2 mg/mL) Single Dose Flexible Container

Product Updates

NDC and Packaging Update for Heparin Sodium in Sodium Chloride Injection Flexible Container, Multiple Presentations

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Update for Magnesium Sulfate in Water for Injection Flexible Container, Multiple Presentations

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/500 mL (50 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Change for Heparin Sodium in 5% Dextrose Injection 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container